Marshall Wace
NUVL

Marshall Wace’s Nuvalent NUVL Stock Holding History

Marshall Wace’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.8M Buy
152,122
+148,928
+4,663% +$16M 0.01% 752
2026
Q1 		$327K Sell
3,194
-20,736
-87% -$2.11M ﹤0.01% 2620
2025
Q4 		$2.41M Buy
+23,930
New +$2.36M ﹤0.01% 1493
2025
Q3 		– Sell
-61,486
Closed -$4.69M – 3241
2025
Q2 		$4.69M Sell
61,486
-360,027
-85% -$26.3M 0.01% 1167
2025
Q1 		$29.9M Buy
421,513
+60,473
+17% +$4.73M 0.04% 402
2024
Q4 		$28.3M Buy
361,040
+219,336
+155% +$20.5M 0.03% 440
2024
Q3 		$14.5M Buy
141,704
+57,623
+69% +$4.78M 0.02% 619
2024
Q2 		$6.38M Buy
84,081
+77,229
+1,127% +$5.49M 0.01% 905
2024
Q1 		$515K Sell
6,852
-248
-3% -$19.7K ﹤0.01% 1909
2023
Q4 		$522K Sell
7,100
-34,247
-83% -$2.12M ﹤0.01% 1705
2023
Q3 		$1.9M Buy
+41,347
New +$1.84M ﹤0.01% 1244
2023
Q1 		– Sell
-60,581
Closed -$1.8M – 2971
2022
Q4 		$1.8M Sell
60,581
-21,430
-26% -$598K ﹤0.01% 1783
2022
Q3 		$1.59M Buy
82,011
+54,630
+200% +$914K ﹤0.01% 2157
2022
Q2 		$372K Buy
+27,381
New +$290K ﹤0.01% 2939

Other funds holding NUVL

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Marshall Wace's NUVL Position: Q2 2026 in Review

Marshall Wace increased its Nuvalent (NUVL) stake by 4,663% in Q2 2026, buying an estimated $16M and bringing the position to 152,122 shares worth $18.8M. The position accounts for 0.01% of the portfolio, ranked #752.

Marshall Wace first reported a position in NUVL in Q2 2022 and has held it in 14 quarters since. The position peaked at $29.9M in Q1 2025. 292 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Marshall Wace held 152,122 shares of Nuvalent worth $18.8M as of Q2 2026.
  • Marshall Wace bought 148,928 Nuvalent shares in Q2 2026, an estimated $16M.
  • Nuvalent made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #752 holding.
  • Marshall Wace first reported a position in Nuvalent in Q2 2022 and has held it in 14 quarters since.
  • Marshall Wace's Nuvalent position peaked at $29.9M in Q1 2025.
  • 292 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.